Annual FCF
-$336.30 M
-$31.83 M-10.45%
December 31, 2023
Summary
- As of February 8, 2025, DNA annual free cash flow is -$336.30 million, with the most recent change of -$31.83 million (-10.45%) on December 31, 2023.
- During the last 3 years, DNA annual FCF has fallen by -$142.65 million (-73.66%).
- DNA annual FCF is now -402.83% below its all-time high of -$66.88 million, reached on December 31, 2019.
Performance
DNA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$118.59 M
-$7.17 M-6.43%
September 30, 2024
Summary
- As of February 8, 2025, DNA quarterly free cash flow is -$118.59 million, with the most recent change of -$7.17 million (-6.43%) on September 30, 2024.
- Over the past year, DNA quarterly FCF has dropped by -$57.31 million (-93.53%).
- DNA quarterly FCF is now -1011.12% below its all-time high of -$10.67 million, reached on September 30, 2021.
Performance
DNA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$387.26 M
-$40.66 M-11.73%
September 30, 2024
Summary
- As of February 8, 2025, DNA TTM free cash flow is -$387.26 million, with the most recent change of -$40.66 million (-11.73%) on September 30, 2024.
- Over the past year, DNA TTM FCF has dropped by -$50.96 million (-15.15%).
- DNA TTM FCF is now -452.70% below its all-time high of -$70.07 million, reached on March 31, 2021.
Performance
DNA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
DNA Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.4% | -93.5% | -15.2% |
| 3 y3 years | -73.7% | -93.5% | -15.2% |
| 5 y5 years | -402.8% | - | - |
DNA Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -10.4% | at low | -405.1% | +30.5% | -46.8% | +4.4% |
| 5 y | 5-year | -402.8% | at low | -1011.1% | +30.5% | -452.7% | +4.4% |
| alltime | all time | -402.8% | at low | -1011.1% | +30.5% | -452.7% | +4.4% |
Ginkgo Bioworks Holdings Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$118.59 M(+6.4%) | -$387.26 M(+11.7%) |
| Jun 2024 | - | -$111.42 M(+16.1%) | -$346.60 M(+7.6%) |
| Mar 2024 | - | -$95.97 M(+56.6%) | -$322.24 M(-4.2%) |
| Dec 2023 | -$336.30 M(+10.5%) | -$61.28 M(-21.4%) | -$336.30 M(-17.0%) |
| Sep 2023 | - | -$77.93 M(-10.5%) | -$405.20 M(+9.8%) |
| Jun 2023 | - | -$87.07 M(-20.9%) | -$369.10 M(-5.6%) |
| Mar 2023 | - | -$110.03 M(-15.5%) | -$391.02 M(+28.4%) |
| Dec 2022 | -$304.47 M | -$130.18 M(+211.2%) | -$304.47 M(-11.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$41.83 M(-61.6%) | -$344.95 M(+9.9%) |
| Jun 2022 | - | -$108.98 M(+364.2%) | -$313.79 M(+19.0%) |
| Mar 2022 | - | -$23.48 M(-86.2%) | -$263.75 M(-15.0%) |
| Dec 2021 | -$310.34 M(+60.3%) | -$170.66 M(+1498.9%) | -$310.34 M(+122.2%) |
| Sep 2021 | - | -$10.67 M(-81.9%) | -$139.68 M(+8.3%) |
| Jun 2021 | - | -$58.95 M(-15.9%) | -$129.01 M(+84.1%) |
| Mar 2021 | - | -$70.07 M | -$70.07 M |
| Dec 2020 | -$193.65 M(+189.5%) | - | - |
| Dec 2019 | -$66.88 M | - | - |
FAQ
- What is Ginkgo Bioworks Holdings annual free cash flow?
- What is the all time high annual FCF for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings annual FCF year-on-year change?
- What is Ginkgo Bioworks Holdings quarterly free cash flow?
- What is the all time high quarterly FCF for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings quarterly FCF year-on-year change?
- What is Ginkgo Bioworks Holdings TTM free cash flow?
- What is the all time high TTM FCF for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings TTM FCF year-on-year change?
What is Ginkgo Bioworks Holdings annual free cash flow?
The current annual FCF of DNA is -$336.30 M
What is the all time high annual FCF for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high annual free cash flow is -$66.88 M
What is Ginkgo Bioworks Holdings annual FCF year-on-year change?
Over the past year, DNA annual free cash flow has changed by -$31.83 M (-10.45%)
What is Ginkgo Bioworks Holdings quarterly free cash flow?
The current quarterly FCF of DNA is -$118.59 M
What is the all time high quarterly FCF for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high quarterly free cash flow is -$10.67 M
What is Ginkgo Bioworks Holdings quarterly FCF year-on-year change?
Over the past year, DNA quarterly free cash flow has changed by -$57.31 M (-93.53%)
What is Ginkgo Bioworks Holdings TTM free cash flow?
The current TTM FCF of DNA is -$387.26 M
What is the all time high TTM FCF for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high TTM free cash flow is -$70.07 M
What is Ginkgo Bioworks Holdings TTM FCF year-on-year change?
Over the past year, DNA TTM free cash flow has changed by -$50.96 M (-15.15%)